TMCnet News

SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Juno Therapeutics Inc. And Encourages Investors with Losses to Contact the Firm
[July 28, 2016]

SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Juno Therapeutics Inc. And Encourages Investors with Losses to Contact the Firm


Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Juno Therapeutics Inc. ("Juno" or the "Company") (Nasdaq: JUNO). Investors who purchased or otherwise acquired shares between June 4, 2016 and July 7, 2016 (the "Class Period") are encouraged to contact the firm in advance of the September 12, 2016 lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, clik here to participate. In addition, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA (News - Alert) 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm's website at http://www.Goldberglawpc.com, or by email at [email protected].



The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company failed to disclose that a patient died during a clinical trial for its product candidate in May 2016. Juno was thus trading at artificially inflated prices and some insiders participated in heavy selling of shares until July 7, 2016. On July 7, 2016 the Company announced the May 2016 death and two additional deaths during clinical trial, and the Food and Drug Administration put a hold on the trial. After the announcement of this news, shares of Juno dropped in value significantly.


Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]